Acylation stimulating protein/C3adesArg in the metabolic states: role of adipocyte dysfunction in obesity complications
The Journal of Physiology · 2024
DOI: 10.1113/jp285127 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Reza Rezvani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Adipocytes, Adipose Tissue, Complement C3a. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 136 Literaturangaben.
Abstract (Originalsprache)
Adipose tissue, as an endocrine organ, secretes several adipocyte‐derived hormones named ‘adipokines’ that are implicated in regulating energy haemostasis. Substantial evidence shows that white adipose tissue‐derived adipokines mediate the link between obesity‐related exogenous factors (like diet and lifestyle) and various biological events (such as pre‐ and postmenopausal status) that have obesity consequences (cardiometabolic disorders). One of the critical aetiological factors for obesity‐related diseases is the dysfunction of adipokine pathways. Acylation‐stimulating protein (ASP) is an adipokine that stimulates triglyceride synthesis and storage in adipose tissue by enhancing glucose and fatty acid uptake. ASP acts via its receptor C5L2. The primary objective of this review is to address the existing gap in the literature regarding ASP by investigating its diverse responses and receptor interactions across multiple determinants of obesity. These determinants include diet composition, metabolic disorders, organ involvement, sex and sex hormone levels. Furthermore, this article explores the broader paradigm shift from solely focusing on adipose tissue mass, which contributes to obesity, to considering the broader implications of adipose tissue function. Additionally, we raise a critical question concerning the clinical relevance of the insights gained from this review, both in terms of potential therapeutic interventions targeting ASP and in the context of preventing obesity‐related conditions, highlighting the potential of the ASP–C5L2 interaction as a pharmacological target. In conclusion, these findings validate that obesity is a low‐grade inflammatory status with multiorgan involvement and sex differences, demonstrating dynamic interactions between immune and metabolic response determinants. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Nutrition, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
- Centre de Recherche Institut Universitaire de Cardiologie & Pneumologie de Québec, Université Laval, Québec, Québec, Canada.
ORCID-Profile: Reza Rezvani
Zitieren
APA
Rezvani, R., Shadmand Foumani Moghadam, M. R., & Cianflone, K. (2024). Acylation stimulating protein/C3adesArg in the metabolic states: role of adipocyte dysfunction in obesity complications. The Journal of Physiology. https://doi.org/10.1113/jp285127
Vancouver
Rezvani R, Shadmand Foumani Moghadam MR, Cianflone K. Acylation stimulating protein/C3adesArg in the metabolic states: role of adipocyte dysfunction in obesity complications. The Journal of Physiology. 2024. doi:10.1113/jp285127
BibTeX
@article{Rezvani2024,
author = {Rezvani, Reza and Shadmand Foumani Moghadam, Mohammad Reza and Cianflone, Katherine},
title = {Acylation stimulating protein/C3adesArg in the metabolic states: role of adipocyte dysfunction in obesity complications},
journal = {The Journal of Physiology},
year = {2024},
doi = {10.1113/jp285127}
}
EUVIMED